Novartis' CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a "very difficult situation." ...

Novartis is doubling down on the Triangle. The drug giant announced Thursday that it will build a 56,200-square-foot active ...

Novartis Pharmaceuticals on Thursday announced plans to build a facility in Morrisville.

The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities ...

With the addition of the new site, Novartis will operate five facilities across three locations in North Carolina.

Novartis CEO Vas Narasimhan is doubling down on his $5 billion peak sales projection for Pluvicto, even as the company has ...

At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew ...

Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...

Novartis is “continuing to evaluate” the in vivo CAR-T space, although the pharma’s CEO has told Fierce Biotech that no deals ...

A Switzerland-based drugmaker plans to build a new pharmaceutical manufacturing facility in Morrisville, expanding its ...

Phase 2 data from PTC Therapeutics showed that the Novartis-partnered Huntington’s disease asset slowed progression by more ...

Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...